Abivax S.A. (ABVX) experienced a significant intraday surge of 5.08%, reflecting strong investor interest in the stock.
The price movement follows a report from Truist Financial, where analyst Gregory Renza maintained a Buy rating on Abivax SA Sponsored ADR. This positive endorsement likely contributed to the increased buying activity and the subsequent rise in the stock price.